These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 140989)

  • 1. Prevention of obesity in Avy/a mice by dehydroepiandrosterone.
    Yen TT; Allan JA; Pearson DV; Acton JM; Greenberg MM
    Lipids; 1977 May; 12(5):409-13. PubMed ID: 140989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of obesity in Avy/a mice by 5alpha-androstan-17-one.
    Yen TT; Allan JA; Pearson DV; Acton JM
    Experientia; 1978 Dec; 34(12):1542-3. PubMed ID: 729710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone: an anti-obesity and anti-carcinogenic agent.
    Schwartz AG; Hard GC; Pashko LL; Abou-Gharbia M; Swern D
    Nutr Cancer; 1981; 3(1):46-53. PubMed ID: 6213940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiobesity and metabolic activities of LY79771 in obese and normal mice.
    Yen TT
    Int J Obes; 1984; 8(1):69-78. PubMed ID: 6368435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. The Obesity Research Program.
    Abadie JM; Wright B; Correa G; Browne ES; Porter JR; Svec F
    Diabetes; 1993 May; 42(5):662-9. PubMed ID: 7683287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice.
    Yen TT; Allan JA; Yu PL; Acton MA; Pearson DV
    Biochim Biophys Acta; 1976 Aug; 441(2):213-20. PubMed ID: 952988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dehydroepiandrosterone and clofibric acid treatments in obese Zucker rats.
    Mohan PF; Cleary MP
    J Nutr; 1989 Mar; 119(3):496-501. PubMed ID: 2564047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response effects of ectopic agouti protein on iron overload and age-associated aspects of the Avy/a obese mouse phenome.
    Wolff GL; Whittaker P
    Peptides; 2005 Oct; 26(10):1697-711. PubMed ID: 15982784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermogenesis and weight control.
    Yen TT; McKee MM; Stamm NB
    Int J Obes; 1984; 8 Suppl 1():65-78. PubMed ID: 6152557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dehydroepiandrosterone on obesity and glucose-6-phosphate dehydrogenase activity in the lethal yellow mouse (strain 129/Sv-Ay/Aw).
    Granholm NH; Staber LD; Wilkin PJ
    J Exp Zool; 1987 Apr; 242(1):67-74. PubMed ID: 2955075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of dehydroepiandrosterone treatment in rats on mitochondrial respiration.
    Mohan PF; Cleary MP
    J Nutr; 1991 Feb; 121(2):240-50. PubMed ID: 1825328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anorectic effect of dehydroepiandrosterone and d-Fenfluramine on the obese Zucker rat.
    Gillen G; Porter JR; Svec F
    Physiol Behav; 1999 Aug; 67(2):173-9. PubMed ID: 10477047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone.
    Schwartz AG
    Cancer Res; 1979 Mar; 39(3):1129-32. PubMed ID: 154968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
    Lemieux C; Picard F; Labrie F; Richard D; Deshaies Y
    Obes Res; 2003 Mar; 11(3):477-90. PubMed ID: 12634448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine.
    Rowland NE; Marshall M; Robertson K
    Eur J Pharmacol; 2001 May; 419(1):61-4. PubMed ID: 11348631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese-hyperglycemic mutant mice.
    Coleman DL
    Prog Clin Biol Res; 1988; 265():161-75. PubMed ID: 2970093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
    Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
    Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-obesity effect of two different levels of dehydroepiandrosterone in lean and obese middle-aged female Zucker rats.
    Cleary MP; Zisk JF
    Int J Obes; 1986; 10(3):193-204. PubMed ID: 2944850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the relationships among obesity, plasma insulin and hepatic lipogenic enzymes in "viable yellow obese" mice (Avy/a).
    Yen TT; Greenberg MM; Yu PL; Pearson DV
    Horm Metab Res; 1976 May; 8(3):159-66. PubMed ID: 7520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.
    Kimura M; Tanaka S; Yamada Y; Kiuchi Y; Yamakawa T; Sekihara H
    Endocrinology; 1998 Jul; 139(7):3249-53. PubMed ID: 9645700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.